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Diethyl 5-acetyl-4-methyl-6-(2-fluorophenylimino)-6H-thiopyran-2,3-dicarboxylate (3TM) was synthesized 
and the antiproliferative activity of 3TM is reported here. Compound 3TM inhibits the growth of human 
colon cancer HCT-15 with an IC50 value of 4.5 µM and breast cancer MCF-7 with an IC50 value of 7 µM in a 
dose/time dependent manner by using sulforhodamine B assay. Moreover, suppression of clonogenic 
activity occurs after exposure to 3TM at a concentration of 3 µM for HCT-15 and of 5 µM for MCF-7. The 










The search for new biologically active agents is an 
important task for medicinal chemists, especially for 
investigators who are attempting to develop antitumor 
agents. In this regards, heterocyclic compounds have 
varying utility and interesting chemistry and are important 
due to their role in biological and chemical systems in 
various ways. Thiopyrans are used as key units in 
bioorganic chemistry and as versatile building blocks in 
organic synthesis (Vedejs and Krafft, 1982; Hollick et al., 
2003; Yoshimura et al., 2009) and has been reported to 
have various pharmaceutical activities such as anti-
bacteria (Brown et al., 2002), anti-hyperplasia (Quaglia et 
al., 2002), anti-psychiatric (Van Vliet et al., 2000), and 
anticancer activities (Wang et al., 2006; Sugita et al., 
2001). In view of their wide range of biological activities, 
we decided to synthesize diethyl 5-acetyl-4-methyl-6-(2-
fluoro-phenylimino)-6H-thiopyran-2,3-dicarboxylate (3TM) 
and study in detail the dose/time-dependent antipro-
liferative activity  and  the  anticlonogenic  properties  of  
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HCT-15 (colon cancer). There is evidence that anticancer 
activity was due to the interaction between the drug and 
the base pairs of DNA and interference with normal 
functioning of the enzyme topoisomerase II that was 
involved in the breaking and releasing of DNA strands 
(Kidwai et al., 2006). In our previous works, we reported 
synthesis and biological evaluation of different 
heterocyclic compounds and their DNA binding 
interaction studies (Nafisi et al., 2008; Rajabi et al., 2010; 
Mehrzad et al., 2010; Bertini et al., 2010). Therefore, we 
decided to study the effect of ligand complexation on 




MATERIALS AND METHODS 
 
Trypsin, trypan blue, antibiotic and antimycotic agent, fetal bovine 
serum (FBS), sulforhodamine B (SRB), and dimethyl sulfoxide 
(DMSO) were purchased from Sigma Chemical Co. Chemicals and 
solvents for DPTM synthesis were purchased from Sigma-Aldrich 
Italia. NMR spectra were obtained with a Varian Gemini 200MHz 
spectrometer. Chemical shifts (d) are reported in parts per million 
downfield from tetramethylsilane using solvent references. Electron 
impact (EI, 70 eV) mass spectra were obtained  on a  ThermoQuest 




Finnigan GCQ Plus mass spectrometer. Chromatographic 
separations were performed on silica gel columns by flash 
(Kieselgel 40, 0.04 – 0.06 mm; Merck) or gravity column (Kieselgel 
60, 0.063–0.200 mm; Merck) chromatography. Reactions were 
followed by thin layer chromatography on Merck aluminum silica gel 
(60 F254) sheets that were visualized under a UV lamp. 
Evaporation was performed in vacuo (rotating evaporator).  
 
 
Chemical synthesis of 3TM 
 
To a stirred solution of dimethyl acetylenedicarboxylate, 2 (2 mmol) 
and arylisothiocyanate 1, (2 mmol) in 10 ml of acetonitrile was 
added to a mixture of 1,3-dicarbonyl (2 mmol) and sodium hydride 
(2 mmol) in acetonitrile at room temperature. The reaction mixture 
was stirred for 8 h. The solvent was removed under reduced 
pressure and the residue was separated by silica gel column 
chromatography (Merck 230 - 400 mesh) using n-hexane-EtOAc 
(5:1) as eluent to give 3TM. Oil, yield: 0.61 g (85%). IR (KBr) 
(max/cm-1): 1729 (C=O), 1719 (C=O), 1643 (C=O), 1540, 1435, 
1327, 1210, 1100 cm-1; 1H-NMR (500MHz, CDCl3):  = 1.27 (3 H, t, 
3J = 7.2 Hz, Me), 1.37 ( 3 H, t, 3J = 7.2 Hz, Me), 2.05 (3 H, s, Me), 
2.52 (3 H, s, Me), 4.25 (2 H, q, 3J = 7.2 Hz, OCH2), 4.37 (2 H, q, 3J 
= 7.2 Hz, OCH2), 6.86-7.13 (4 H, m, 4 CH); 13C-NMR (125.7MHz, 
CDCl3):  = 13.9 (Me), 14.0 (Me), 17.4 (Me), 30.7 (Me), 62.4 
(OCH2), 63.2 (OCH2), 116.7 (d, 2JCF = 19.5 Hz, CH), 125.0 (d, 4JCF = 
3.2 Hz, CH), 126.0 (d, 3JCF = 7.5 Hz, CH), 129.0 (C), 130.4 (d, 3JCF 
= 7.3 Hz, CH), 132.4 (C), 134.0 (C), 135.8 (C), 136.5 (d, 2JCF = 72.4 
Hz, C-N), 151.2 (d, 1JCF = 285.4 Hz, C), 155.8 (C=N), 160.7 (C=O), 
166.3 (C=O), 202.7 (C=O); Anal. Calcd for C20H20FNO5S: C, 59.25; 




Cell culture and cell morphology 
 
Human breast cancer MCF-7 and colon cancer HCT-15 cell lines 
were supplied from ATCC and grown as a monolayer in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% FBS, 2 mM 
glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin. 
Cultures were maintained at 37°C with 5% CO2 in a humidified 
atmosphere. Cell shape and morphology of treated and untreated 
cells were viewed using an inverted phase-contrast microscope 




In vitro evaluation of cytotoxic activity 
 
Growth activity of 3TM in vitro was evaluated by the SRB assay. 
3TM stock solution (10 mM in DMSO) was stored at 4°C and diluted 
with Dulbecco’s modified Eagle’s medium to 0.1 to 1 µM at room 
temperature before treatment. The final percentage of DMSO in the 
reaction mixture was <1% (v/v). Cells (2 × 103 cells/well) were 
plated in 96-wells plates and incubated in medium for 24 h. Serial 
dilutions of individual compounds were added. The plates were 
incubated at 37°C for 72 h before addition of 3TM. The assay was 
terminated by the addition of 50 µl of ice-cold trichloroacetic acid 
(final concentration, 10% TCA) and incubated for 60 min at 4°C. 
The plates were washed five times with distilled water and air-dried. 
SRB solution (50 µl) at 0.4% (w/v) in 1% acetic acid was added to 
each of the wells, and plates were incubated for 30 min at room 
temperature. The residual dye was removed by washing five times 
with 1% acetic acid. The plates were air-dried or under hood. 
Bound stain was subsequently eluted with 10 mM Trizma base, and 
the absorbance was read on an ELISA plate reader at a wavelength 
of 540 nm and used as a relative measure of viable cell number. 





equation: percentage growth inhibition (1-At/Ac) x 100, where At and 
Ac represent the absorbance in treated and control cultures, 






MCF-7 and HCT-15 cells were plated at a density of 700 cells/well 
in 12-well plates and treated with 0, 5, 10, 25, 50, 80 and 100 µM 
3TM for 14 days. Plates were rinsed in PBS; colonies were 
methanol-fixed and stained with 10% Giemsa; and clones were 
counted under a light microscope. 
 
 
DNA titration experiments 
 
The absorbance at 260 and 280 nm was recorded, in order to 
check the protein content of DNA solution. DNA (5 mg/ml) was 
dissolved in distilled water (pH 7) at 4°C for 24 h with occasional 
stirring to ensure the formation of a homogeneous solution. The 
final concentration of the DNA solution was determined 
spectrophotometrically at 260 nm using molar extinction coefficient 
260 = 6600 cm-1 M-1 (expressed as molarity of phosphate groups). 
The UV absorbance at 260 nm of a diluted solution (1/187.5) of 
DNA used in our experiments was 0.666 and the final concentration 
of the DNA solution was 12.5 mM in DNA. The appropriate amounts 
of 3TM (0.05 to 12.5 mM) were prepared in distilled water and 
added dropwise to DNA solution in order to attain the desired 
ligand/DNA molar ratios (r) of 1/40, 1/20, 1/10, 1/5, 1/2 and 1 with a 
final DNA concentration of 6.25 mM. The pH of the solutions was 
adjusted at 7.0 ± 0.2 using NaOH solution. 
 
 
RESULTS AND DISCUSSION 
 
Chemical synthesis of 3TM 
 
Synthesis of diethyl 5-acetyl-4-methyl- 6-(2-fluoro-
phenylimino)-6H-thiopyran-2,3-dicarboxylate is described 
via reaction between 1,3-dicarbonyls, electron deficient 
acetylenic compounds such as dimethyl acetylenedi-
carboxylate (DMAD) and aryleisothiocyanate in the 
presence of sodium hydride as a base (Figure 1) in 
acetonitrile at room temperature reaction mixture which 
was stirred for 8 h. The solvent was removed under 
reduced pressure and the residue was separated by 
silica gel column chromatography to give 3TM.  
 
 
Cytotoxic evaluation in vitro 
 
The compound 3TM was evaluated for its growth 
inhibitory effect on HCT-15 colon and MCF-7 breast 
cancer cell lines. The cells were treated with 3TM at 
different concentrations, ranging from 1 to 100 µM, for 3 
days using the SRB assay (Figure 2A and B). In the 
presence of different doses of 3TM, the cells were 
inhibited ranging from 10 to 90% with a loss of viable 
cells (Figure 2C and D). 3TM inhibited the proliferation of 
MCF-7 and HCT-15 cells in a concentration and time-
dependent     manner.  The   IC50    was    determined    by  











interpolation from dose-response curves. The percentage 
growth inhibition was calculated by comparison of the 
absorbance of treated versus control cells. IC50 
calculated for HCT-15 was 4.5 and 7 µM for MCF-7 
(Figure 2C and D). Control group showed regular 
polygonal shape, and cell antennas were short. The cell 
morphology of treated cells was affected by 3TM 
treatment; loss of adhesion, rounding, cell shrinkage and 





Analysis of clonogenic activity in HCT-15 and MCF-7 
cells treated with 3TM at concentrations ranging from 0.5 
to 100 µM of 3TM for 14 days revealed a complete 
inhibition of colony formation at 3 µM for HCT-15 and 5 
µM for MCF-7 cells, whereas concentrations lower than 
10 µM were ineffective (Figure 2E and F). 
The percentage of growth inhibition was calculated by 
using the equation: (1- At/Ac) x 100, where At and Ac 
represent the absorbance in treated and control cultures, 
respectively. IC50 was determined by interpolation from 
dose-response curves. Dose-response curve of 3TM 
mediated inhibition of HCT-15 (E) and MCF-7 (F) cell 
colony formation. 
DNA binding study 
 
DNA as a carrier of genetic information is a major target 
for drug interaction because of the ability to interfere with 
transcription (gene expression and protein synthesis) and 
DNA replication, a major step in cell growth and division. 
The calculation of the overall binding constants was 
carried out on the basis of UV absorption as reported. 
The equilibrium for 3TM and DNA complex can be 
described as follows:  
 
[DNA + 3TM]  [DNA - 3TM]K3TM  
 
K 3TM = [DNA
 - 3TM]/ [DNA][3TM] 
 
The double reciprocal plot of 1/[A -A0] vs 1/[ligand] is 
linear and the association binding constant (K) is 
calculated from the ratio of the intercept on the vertical 
coordinate axis to the slope (Tajmir-Riahi et al., 1995; 
Mandeville et al., 2010; Froehlich et al., 2011). 
Concentrations of the complexed ligand were determined 
by subtracting absorbance of free DNA at 260 nm from 
those of the complexed DNA. Concentration of the free 
ligand was determined by subtraction of complexed 
ligand from total ligand used for the experiment. Our data 
shows  that  1/[complexed ligand]   almost   proportionally  
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Figure 2. Effects of 3TM on the proliferation of HCT-15 and MCF-7. (A) Effect of 3TM on the proliferation of 
HCT-15; (B) effects of 3TM on the proliferation of MCF-7; (C) inhibition of 3TM on HCT-15 growth; (D) inhibition 




increases as a function of 1/[free ligand] (Figure 3). 
Therefore, an overall binding constant, K3M-DNA = 2.4  x 
104 M-1 can be estimated for 3TM –DNA. 
Conclusion 
 
We reported here that  the  compound  diethyl-5-acetyl-4- 






Figure 3. The plot of 1/(A-A0) vs. 1/L for DNA and iPA complexes at 





xylate was synthesized and characterized. The 
antiproliferative effects mediated by 3TM on the growth of 
HCT-15 and MCF-7 cell lines, monitored at different 
concentrations, ranging from 1 to 100 µM for 3 days and 
IC50, calculated by SRB assay, were 4.5 µM for HCT-15 
and 7 µM for MCF-7. This study of these two human 
cancer cell lines revealed suppression of clonogenic 
activity after exposure to 3TM at a concentration of 4 µM 
for HCT-15 and of 5 µM for MCF-7. On the other hand, 
the connection between DNA binding and cytotoxicity of 
3TM is supported by a large body of literature. Our result 
from structural analysis showed interaction of 3TM with 
DNA and the binding constant value K3M-DNA = 2.4  x 10
4 
M-1 suggest that 3TM interacts with DNA in good mode. 
Further research is required in order to demonstrate 
whether this binding effect may be related to DNA 
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